Dimethyltryptamine molecule:

Image from PubChem

DMT Clinical Trials


Inhaled N, N-Dimethyltryptamine: a Phase I Study in Healthy Adults


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05573568

Organisation Name: Biomind Labs Inc.

Overal Status: Completed

Start Date: June 1, 2022

Last Update: November 22, 2022

Lead Sponsor: Biomind Labs Inc.

Brief Summary: This study aims to evaluate the acute and subacute effects of an inhaled N, N-Dimethyltryptamine in healthy individuals.

Conditions:
  • Healthy Volunteers


Total execution time in seconds: 0.29821109771729